News for Agilent Technologies, Inc. (A1GI34.SA)

On July 1, 2025, Padraig Mcdonnell, President and CEO of Agilent Technologies Inc (A), sold 1,508 shares of the company, according to a SEC Filing. Following th

**media[651771]**

Shares of Agilent Technologies Inc (A) surged 3.58% in mid-day trading on Jun 10. The stock reached an intraday high of $121.03, before settling at $120.93,

Agilent Technologies, Inc. (NYSE:A) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ETCompany ParticipantsPadraig McDonnell - CEO,...

Agilent Technologies (A) experienced stock pressure prior to its earnings announcement, influenced primarily by challenges within the life science tools segment

Shares of Agilent Technologies Inc (A) surged 3.02% in mid-day trading on May 29. The stock reached an intraday high of $116.99, before settling at $114.23,

Agilent Technologies Inc (A) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. With

On May 29, 2025, JP Morgan maintained its

In the latest market session, Agilent (A) experienced a significant upsurge, with its stock price increasing by $5.68 to reach $116.56. This increase marks a no

U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 100 points on Thursday. Shares of Veeva Systems Inc. VEEV rose sharply during Thursday...

Agilent Technologies Inc. (NYSE:A) reported second-quarter 2025 sales of $1.67 billion on Wednesday, almost in line with the consensus of $1.63 billion, representing growth of 6% reported and up 5.3% core year-over-year. The Life Sciences and Diagnostics Markets Group (LDG) reported second-quarter revenue of $654 million, an increase of 8% reported and 3% core year-over-year. LDG’s operating margin for the quarter was 19.7%. The Agilent CrossLab Group (ACG) reported second-quarter revenue of $71

UBS has revised its price target for Agilent (A), lowering it from $150 to $130, while maintaining a Neutral stance on the stock. Despite the fluctuating macroe

JPMorgan has revised its price target for Agilent (A), lowering it from $160 to $155, while maintaining an Overweight rating on the shares. Despite this adjustm

Revenue: $1.67 billion, representing 6% reported growth and 5.3% core growth year-over-year.Operating Margin: 25.1%, absorbing incremental tariff costs.Earning

Agilent Technologies, Inc. (A) has announced a significant expansion of its Board of Directors, increasing its size from 10 to 12 members. This strategic move

Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have b

Agilent Technologies (A) Dividend and Financial Performance Summary: Agilent Technologies declared a quarterly dividend of $0.07 per share for Class A and C

Summary Agilent Technologies Inc (A) announced that its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR certification as a Companion Diagno

Agilent Technologies Inc. (A) has achieved a significant milestone with the European IVDR certification of its PD-L1 IHC 22C3 pharmDx assay. This certification